MADISON, Wis. – A federal agency has upheld a patent that covers embryonic stem cell research, rejecting a challenge from critics who say the patents are hindering research.
An examiner with the U.S. Patent and Trademark Office ruled this week that one of three patents can stand. A challenge to two other patents remains pending.